These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 25760770)
1. Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemia. Fitting J; Blume T; Ten Haaf A; Blau W; Gattenlöhner S; Tur MK; Barth S MAbs; 2015; 7(2):390-402. PubMed ID: 25760770 [TBL] [Abstract][Full Text] [Related]
2. In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA' in a human acute myeloid leukemia xenograft tumor model. Tur MK; Huhn M; Jost E; Thepen T; Brümmendorf TH; Barth S Int J Cancer; 2011 Sep; 129(5):1277-82. PubMed ID: 21077160 [TBL] [Abstract][Full Text] [Related]
3. Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells. Tur MK; Huhn M; Thepen T; Stöcker M; Krohn R; Vogel S; Jost E; Osieka R; van de Winkel JG; Fischer R; Finnern R; Barth S Cancer Res; 2003 Dec; 63(23):8414-9. PubMed ID: 14679004 [TBL] [Abstract][Full Text] [Related]
4. Construction, expression, and characterization of an anti-tumor immunotoxin containing the human anti-c-Met single-chain antibody and PE38KDEL. Liu Z; Feng Z; Zhu X; Xu W; Zhu J; Zhang X; Fan Z; Ji G Immunol Lett; 2013 Jan; 149(1-2):30-40. PubMed ID: 23026237 [TBL] [Abstract][Full Text] [Related]
5. Efficient targeting of CD13 on cancer cells by the immunotoxin scFv13-ETA' and the bispecific scFv [13xds16]. Grieger E; Gresch G; Niesen J; Woitok M; Barth S; Fischer R; Fendel R; Stein C J Cancer Res Clin Oncol; 2017 Nov; 143(11):2159-2170. PubMed ID: 28669053 [TBL] [Abstract][Full Text] [Related]
6. Target-specific cytotoxic activity of recombinant immunotoxin scFv(MUC1)-ETA on breast carcinoma cells and primary breast tumors. Singh R; Samant U; Hyland S; Chaudhari PR; Wels WS; Bandyopadhyay D Mol Cancer Ther; 2007 Feb; 6(2):562-9. PubMed ID: 17308054 [TBL] [Abstract][Full Text] [Related]
7. Novel conjugates of single-chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells. Stein C; Kellner C; Kügler M; Reiff N; Mentz K; Schwenkert M; Stockmeyer B; Mackensen A; Fey GH Br J Haematol; 2010 Mar; 148(6):879-89. PubMed ID: 20064159 [TBL] [Abstract][Full Text] [Related]
8. The novel multispecies Fc-specific Pseudomonas exotoxin A fusion protein α-Fc-ETA' enables screening of antibodies for immunotoxin development. Klausz K; Kellner C; Derer S; Valerius T; Staudinger M; Burger R; Gramatzki M; Peipp M J Immunol Methods; 2015 Mar; 418():75-83. PubMed ID: 25701195 [TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancer. Wolf P; Alt K; Wetterauer D; Bühler P; Gierschner D; Katzenwadel A; Wetterauer U; Elsässer-Beile U J Immunother; 2010 Apr; 33(3):262-71. PubMed ID: 20445346 [TBL] [Abstract][Full Text] [Related]
10. Isolation and characterizations of a novel recombinant scFv antibody against exotoxin A of Pseudomonas aeruginosa. Shadman Z; Farajnia S; Pazhang M; Tohidkia M; Rahbarnia L; Najavand S; Toraby S BMC Infect Dis; 2021 Mar; 21(1):300. PubMed ID: 33761869 [TBL] [Abstract][Full Text] [Related]
11. The novel immunotoxin HM1.24-ETA' induces apoptosis in multiple myeloma cells. Staudinger M; Glorius P; Burger R; Kellner C; Klausz K; Günther A; Repp R; Klapper W; Gramatzki M; Peipp M Blood Cancer J; 2014 Jun; 4(6):e219. PubMed ID: 24927408 [TBL] [Abstract][Full Text] [Related]
12. Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer. Baiz D; Hassan S; Choi YA; Flores A; Karpova Y; Yancey D; Pullikuth A; Sui G; Sadelain M; Debinski W; Kulik G Neoplasia; 2013 Oct; 15(10):1172-83. PubMed ID: 24204196 [TBL] [Abstract][Full Text] [Related]
13. A new recombinant immunotoxin hscFv-ETA' demonstrates specific cytotoxicity against chronic myeloid leukemia cells in vitro. Zhu X; Tao K; Li Y; Li S; Zhang L; Wang D; Zhong L; Feng W Immunol Lett; 2013; 154(1-2):18-24. PubMed ID: 23954809 [TBL] [Abstract][Full Text] [Related]
14. Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer. Kessler C; Pardo A; Tur MK; Gattenlöhner S; Fischer R; Kolberg K; Barth S J Cancer Res Clin Oncol; 2017 Oct; 143(10):2025-2038. PubMed ID: 28667390 [TBL] [Abstract][Full Text] [Related]
16. Construction and in vitro evaluation of RFT5(scFv)-ETA', a new recombinant single-chain immunotoxin with specific cytotoxicity toward CD25+ Hodgkin-derived cell lines. Barth S; Huhn M; Wels W; Diehl V; Engert A Int J Mol Med; 1998 Jan; 1(1):249-56. PubMed ID: 9852227 [TBL] [Abstract][Full Text] [Related]
17. A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells. Schwemmlein M; Peipp M; Barbin K; Saul D; Stockmeyer B; Repp R; Birkmann J; Oduncu F; Emmerich B; Fey GH Br J Haematol; 2006 Apr; 133(2):141-51. PubMed ID: 16611304 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Resistance to Immunotoxins Containing Dieffenbach M; Pastan I Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32630017 [TBL] [Abstract][Full Text] [Related]
19. A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T cells. Peipp M; Küpers H; Saul D; Schlierf B; Greil J; Zunino SJ; Gramatzki M; Fey GH Cancer Res; 2002 May; 62(10):2848-55. PubMed ID: 12019163 [TBL] [Abstract][Full Text] [Related]
20. Soluble Cytoplasmic Expression and Purification of Immunotoxin HER2(scFv)-PE24B as a Maltose Binding Protein Fusion. Park S; Nguyen MQ; Ta HKK; Nguyen MT; Lee G; Kim CJ; Jang YJ; Choe H Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]